About 22 Trademarks found that are owned by Genenews Limited

BREAST SENTRY

Kits comprising blood drawing apparatus and molecular biological reagents useful for detecting gene expression products, namely, ribonucleic acid (RNA), copy deoxyribonucleotic acids (cDNA), polymerase chain reaction (PCR) products or proteins, as an indication of body state, namely, body health, condition, disease or response to therapeutic treatment, particularly with regard to breast disease and including breast cancer

Color is not claimed as a feature of the mark.

Diagnostic services, namely, diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity, evaluation of clinical trial progress, and drug monitoring and monitoring of patient health progression; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors; computer services, namely, providing access to databases of life sciences information via computer networks in the field of personalized medicine, including phannacogenomic and toxicogenomic information

The mark consists of interlocking arcs design.

Diagnostic assays and test kits comprised of primers, probes, buffers, and reagents for clinical use to diagnose, prognose or treat diseases

Diagnostic kits comprising molecular biological reagents useful for detecting gene expression products, namely, ribonucleic acid (RNA) or proteins, as an indication of body state, namely, health, condition, disease or response to therapeutic treatment

BREAST SENTRY

The mark consists of a shaded circle with a curved swoop design thinner at the top and thickening as it swoops under the circle, with the word "BREASTSENTRY" to the right. The letters "B" and "S" are in upper-case letters. The remaining letters are in lower-case.

PROSTATE SENTRY

MY HEALTH SENTRY

Medical testing for diagnostic or treatment services, namely, drawing blood for testing purposes, and testing blood for patient triage or risk stratification purposes, and determination of likelihood or odds of having a particular disease or condition as an aid to optimize further testing or treatment options for patients

"DIAGNOSTICS"

Diagnostic testing kits for clinical or medical laboratory use, comprising preparations, namely, clinical medical reagents for use in detecting gene expression products, namely, ribonucleic acid (RNA) or proteins, as an indication of body state, namely, body health conditions in the nature of disease or response to therapeutic treatment

(Based on 44(e)) Diagnostic assays and test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for use to diagnose, prognose or predict diseases; prognostic test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins,antibodies and molecular arrays of biological material, for identifying disease risk factors and responses to therapeutic treatment; diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies,and molecular arrays of biological material for clinical or medical use; diagnostic preparations, namely, preparations of extracts and nucleic acids, namely, RNA and cDNA clones for clinical use

(Based on 44(e)) Diagnostic assays and test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for use to diagnose, prognose or predict diseases; prognostic test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins,antibodies and molecular arrays of biological material, for identifying disease risk factors and responses to therapeutic treatment; diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies,and molecular arrays of biological material for clinical or medical use; diagnostic preparations, namely, preparations of extracts and nucleic acids, namely, RNA and cDNA clones for clinical use